Creatine For GLP-1 Users – XWERKS
US$ 24.02
peptide sciences semaglutide reviews Type 2 diabetes: New Ozempic
Description
The GLP-1 and GIP effects on pancreatic beta cells may also improve insulin secretion capacity beyond the effects of weight loss alone
If you prefer managing your healthcare through an app and portal rather than visiting a clinic, Shed is designed for you
Griese M et al
The phase 3 clinical trials are due to finish in May 2026
One article found an increased incidence of aspiration pneumonia among GLP-1 users compared to non-users reporting a hazard ratio of 1.33 (95%CI 1.021.74, p = 0.036) (Australian Diabetes Society, National Association of Clinical Obesity Services, Gastroenterological Society of Australia, and Australian and New Zealand College of Anaesthetists n.d.)
